These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31696474)

  • 1. LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6.
    Chen SG; Wang CH; He RQ; Xu RY; Ji CB
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8878-8887. PubMed ID: 31696474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated Long Noncoding RNA LINC01234 Predicts Unfavorable Prognosis for Colorectal Cancer and Negatively Correlates With KLF6 Expression.
    Jiang X; Zhu Q; Wu P; Zhou F; Chen J
    Ann Lab Med; 2020 Mar; 40(2):155-163. PubMed ID: 31650732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
    Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFAIP8 regulates cisplatin resistance through TAF-Iα and promotes malignant progression of esophageal cancer.
    Zhang DL; Yang N
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4775-4784. PubMed ID: 32432789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA TRERNA1 promotes malignant progression of NSCLC through targeting FOXL1.
    Luo DB; Lv HB; Sun XH; Wang Y; Chu JH; Salai AL
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1233-1242. PubMed ID: 32096153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
    Li Y; Xu J; Guo YN; Yang BB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CASC9 promotes tumorigenesis by affecting EMT and predicts poor prognosis in esophageal squamous cell cancer.
    Gao GD; Liu XY; Lin Y; Liu HF; Zhang GJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):422-429. PubMed ID: 29424900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
    Wang GF; Wen LN
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LACAT1 promotes proliferation of oral squamous cell carcinoma cells by inhibiting microRNA-4301.
    Wang J; Huo F; Wang XR; Xu YY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2427-2435. PubMed ID: 30964168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
    Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway.
    Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
    Cell Cycle; 2018; 17(15):1886-1900. PubMed ID: 30200804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
    Dong Y; Wang ZG; Chi TS
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.